These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty. Robin AL Ophthalmic Surg; 1991 Jan; 22(1):31-7. PubMed ID: 2014108 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty. Ren J; Shin DH; Chung HS; Birt CM; Glover BK; Juzych MS; Hughes BA; Kim C Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082 [TBL] [Abstract][Full Text] [Related]
4. The impact of anti-inflammatory therapy on intraocular pressure reduction following selective laser trabeculoplasty. Realini T; Charlton J; Hettlinger M Ophthalmic Surg Lasers Imaging; 2010; 41(1):100-3. PubMed ID: 20128578 [TBL] [Abstract][Full Text] [Related]
5. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes]. Best UP; Domack H; Schmidt V Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117 [TBL] [Abstract][Full Text] [Related]
6. [Selective laser trabeculoplasty in glaucoma treatment--results during three years follow-up]. Sicáková S; Výborný P Cesk Slov Oftalmol; 2010 Nov; 66(5):204-8. PubMed ID: 21394976 [TBL] [Abstract][Full Text] [Related]
7. The effect of chronic miotic therapy on the results of posterior chamber intraocular lens implantation and trabeculectomy in patients with glaucoma. Chen HS; Steinmann WC; Spaeth GL Ophthalmic Surg; 1989 Nov; 20(11):784-8. PubMed ID: 2616125 [TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure reduction after selective laser trabeculoplasty in primary open angle glaucoma. Gracner T Coll Antropol; 2001; 25 Suppl():111-5. PubMed ID: 11817000 [TBL] [Abstract][Full Text] [Related]
9. Control of chronic simple glaucoma with primary medical, surgical and laser treatment. Migdal C; Hitchings R Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 6)():653-6. PubMed ID: 3310341 [TBL] [Abstract][Full Text] [Related]
10. Laser trabeculoplasty: how little is enough? Frenkel RE; Shin DH; Epstein DL; Hertzmark E; Bohn JL; Hong YJ Ophthalmic Surg Lasers; 1997 Nov; 28(11):900-4. PubMed ID: 9387175 [TBL] [Abstract][Full Text] [Related]
11. Primary argon laser trabeculoplasty vs pilocarpine 2% in primary open angle glaucoma: two years follow-up study. Sharma A; Gupta A Indian J Ophthalmol; 1997 Jun; 45(2):109-13. PubMed ID: 9475029 [TBL] [Abstract][Full Text] [Related]
12. [Predictive factors of successful selective laser trabeculoplasty in open-angle glaucoma]. Gracner T; Naji M; Hudovernik M; Gracner B; Pahor D Klin Monbl Augenheilkd; 2007 Dec; 224(12):922-6. PubMed ID: 18260055 [TBL] [Abstract][Full Text] [Related]
13. [Results of argon laser treatment of 100 eyes with open-angle glaucoma (trabeculoplasty, trabeculoretraction)]. Moulin F; Haut J J Fr Ophtalmol; 1983; 6(8-9):661-70. PubMed ID: 6687151 [TBL] [Abstract][Full Text] [Related]
15. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine. Allf BE; Shields MB Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861 [TBL] [Abstract][Full Text] [Related]
16. Influence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure rise. Dapling RB; Cunliffe IA; Longstaff S Br J Ophthalmol; 1994 Jan; 78(1):30-2. PubMed ID: 7906539 [TBL] [Abstract][Full Text] [Related]
17. The combined use of apraclonidine and pilocarpine during laser iridotomy in a Hispanic population. Fernandez-Bahamonde JL; Alcaraz-Michelli V Ann Ophthalmol; 1990 Dec; 22(12):446-9. PubMed ID: 2078039 [TBL] [Abstract][Full Text] [Related]
18. Argon laser trabeculoplasty or trabeculectomy a prospective randomised block study. Watson PG; Allen ED; Graham CM; Porter GP; Pickering MS Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 1)():55-61. PubMed ID: 3855337 [TBL] [Abstract][Full Text] [Related]